Skip to Primary Navigation

Skip to main content

QOL Medical and CEO fined $47m for kickback scheme

Doctor writing on clipboard
Photo: RunPhoto/Getty Images

Alexander Barzacanos

1 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The company overstated diagnostic claims to boost sales of its flagship product Sucraid.

Pharmaceutical company QOL Medical, and its CEO Frederik E Cooper, have agreed to pay $47m to the Department of Justice over charges that they paid illegal remuneration and therefore submitted false claims to Medicare, TRICARE, VA, and Medicaid, in violation of the False Claims Act (FCA) and Anti-Kickback Statute (AKS).

, , ,